Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Joycelyn P Y, Sim"'
Autor:
Harinder Gill, Rita Yim, Herbert H. Pang, Paul Lee, Thomas S. Y. Chan, Yu‐Yan Hwang, Garret M. K. Leung, Ho‐Wan Ip, Rock Y. Y. Leung, Sze‐Fai Yip, Bonnie Kho, Harold K. K. Lee, Vivien Mak, Chi‐Chung Chan, June S. M. Lau, Chi‐Kuen Lau, Shek‐Yin Lin, Raymond S. M. Wong, Wa Li, Edmond S. K. Ma, Jun Li, Gianni Panagiotou, Joycelyn P. Y. Sim, Albert K. W. Lie, Yok‐Lam Kwong
Publikováno v:
Cancer Medicine, Vol 9, Iss 10, Pp 3371-3382 (2020)
Abstract Clofarabine is active in refractory/relapsed acute myeloid leukemia (AML). In this phase 2 study, we treated 18‐ to 65‐year‐old AML patients refractory to first‐line 3 + 7 daunorubicin/cytarabine induction or relapsing after 3 + 7 in
Externí odkaz:
https://doaj.org/article/2744c5249b7a4f84a43188e34f729a01
Publikováno v:
Annals of Hematology. 102:483-485
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7149abd5fc4fa249d1cf81b4c5c5325
https://doi.org/10.1007/s00277-022-05053-w
https://doi.org/10.1007/s00277-022-05053-w
Autor:
Thomas S. Y. Chan, Albert K. W. Lie, Joycelyn P Y Sim, Eric Tse, Yok-Lam Kwong, Garret M. K. Leung, Yu-Yan Hwang
Publikováno v:
Annals of Hematology. 101:155-163
Graft-versus-host disease (GVHD) is an important complication after allogeneic haematopoietic stem cell transplantation (HSCT). Corticosteroids are the standard first-line treatment. Steroid-resistant/-dependent (SR/D) acute and chronic GVHD (aGVHD,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4c34967180ce2e0f1af6ad1aa97f723
https://doi.org/10.1007/s00277-021-04658-x
https://doi.org/10.1007/s00277-021-04658-x
Autor:
Yu-Yan Hwang, Thomas S. Y. Chan, Florence H. Y. Chan, Chris W. P. Lau, Yan-Yan Luk, Grace W. N. Lau, Ka-Po Chan, Kwan-Hung Leung, Bonnie Kho, June S. M. Lau, Chi-Kuen Lau, Vivien Mak, Sze-Fai Yip, Shek-Ying Lin, Joycelyn P. Y. Sim, Yok-Lam Kwong
Publikováno v:
Annals of hematology. 101(6)
The thrombopoietin mimetic eltrombopag (EPAG) is efficacious in clinical trials of newly diagnosed moderate (M), severe (S) and very severe (vS) aplastic anaemia (AA). Its use in routine practice and resource-constrained settings is not well describe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::781c34aad76ddcd07b9dce574789895c
https://pubmed.ncbi.nlm.nih.gov/35412083
https://pubmed.ncbi.nlm.nih.gov/35412083
Publikováno v:
Annals of Hematology. 99:385-388
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::458388d870a66c62eab4692bdd7bbb08
https://doi.org/10.1007/s00277-019-03856-y
https://doi.org/10.1007/s00277-019-03856-y
Autor:
Garret M K, Leung, Joycelyn P Y, Sim, Yu-Yan, Hwang, Thomas S Y, Chan, Albert K W, Lie, Eric, Tse, Yok-Lam, Kwong
Publikováno v:
Annals of hematology. 101(1)
Graft-versus-host disease (GVHD) is an important complication after allogeneic haematopoietic stem cell transplantation (HSCT). Corticosteroids are the standard first-line treatment. Steroid-resistant/-dependent (SR/D) acute and chronic GVHD (aGVHD,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ce3c97d40775aa0ae54f5207ada8af03
https://pubmed.ncbi.nlm.nih.gov/34767056
https://pubmed.ncbi.nlm.nih.gov/34767056
Publikováno v:
Annals of Hematology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a605b512f54b503ba8933c5a8d044d8f
https://doi.org/10.1007/s00277-020-04042-1
https://doi.org/10.1007/s00277-020-04042-1
Autor:
Harold K. K. Lee, Eric Tse, Yok-Lam Kwong, Joycelyn P Y Sim, Herman S.Y. Liu, Anskar Y.H. Leung, Bonnie Kho, Sze-Fai Yip
Publikováno v:
Blood. 120:1518-1518
Abstract 1518 Patients with relapsed and/or refractory acute myeloid leukemia (AML) have a very dismal outcome and treatments are largely unsatisfactory. Salvage therapy is often limited by drug resistance and organ toxicities in patients who have al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5572d6cf2129ea84b9e38ac35e01852b
https://doi.org/10.1182/blood.v120.21.1518.1518
https://doi.org/10.1182/blood.v120.21.1518.1518